BioSpace News Archive

The U.S. Food and Drug Administration announced that it has awarded 12 new clinical trial research grants totaling more than $15 million over the next four years to enhance the development of medical products for patients with rare diseases.

Axxess, the leading home healthcare technology company, has a positive view of the impact of the forthcoming Patient-Driven Groupings Model (PDGM) for its clients

The Supreme Court of the United States will be reviewing three cases (Altitude Express, Inc. v. Zarda; Bostock v. Clayton County; and R.G. & G.R. Harris Funeral Homes, Inc. v. EEOC) that take up the question of whether employment discrimination based on sexual orientation or gender identity is prohibited by Title VII of the Civil Rights Act of 1964.

The Medical Science Liaison Society (MSL Society), the only 501(c)(3) non-profit organization exclusively dedicated to advancing the global medical science liaison (MSL) profession, announced that it has registered the first-ever International Medical Science Liaison Day, which will occur every year on March 27th starting in 2020.

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced that the company will present at Advances in Immuno-Oncology Congress USA 2019 in San Diego on October 8th at 2:50 PM PDT.

Bexson Biomedical’s Chief Scientific Officer, Jeffrey Becker, M.D., recently spoke at the annual meeting for the American Society of Ketamine Physicians (ASKP) in Denver, CO.

Centene Corporation (NYSE: CNC) announced today that its provider-led North Carolina subsidiary, Carolina Complete Health, has been awarded a contract to provide Medicaid managed care services in Region 4 (Raleigh/Durham area), an expansion to the company’s recent North Carolina Medicaid contract.

DataPath, Inc., a leading developer of technology solutions for employer-sponsored benefits administration, announced an agreement to add HealthPoint Plus telehealth services to its cloud-based Summit platform.

Lab Effects, the longest-running terpene laboratory in the cannabis industry, maintains a zero-tolerance approach to hazardous ingredients found in vape formulas.

Median Technologies (Paris:ALMDT), The Imaging Phenomics Company®, today publishes an update on its performance – unaudited figures – in the third quarter of 2019.